Jazz Pharmaceuticals plc ( JAZZ) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings ...

According to MarketsandMarkets™, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 ...

According to MarketsandMarkets, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 and ...

This clinical-stage biotech develops targeted cancer therapies, leveraging bispecific antibodies and strategic industry partnerships.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2025 and provided financial guidance for 2026.

Jazz Pharmaceuticals is positioned for long-term value creation, with a relief rally following Q4 2025 results and the 2026 ...

Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news ...

BARCELONA, Feb 26 (Reuters) - Spanish drugmaker Grifols reported on Thursday a net profit of 402 million euros ($473.96 ...

GE HealthCare (Nasdaq: GEHC) today announced a 10-year Care Alliance enterprise collaboration with UCSF Health.

Quadria, which manages $4.2 billion in assets, said it completed the take-private acquisition of Apex Healthcare on Tuesday. The deal values Apex, which makes pharmaceuticals, consumer healthcare ...

UCSF Health formed a collaboration with a large radiology equipment provider to enable expanded radiologic technologist (rad tech) education, magnetic resonance (MR) excellence, and remote imaging ...